Showing all 21 results
Abacavir & Lamivudine Tablets.
FreeProduct Composition & Strength
We supply this product in the globally standardized “600/300” ratio, optimized for maximum efficacy with a convenient once-daily dosing schedule.
Active Ingredient Strength Primary Clinical Function Abacavir (as Sulfate) USP/BP 600 mg The Guanosine Analogue: Stops viral DNA synthesis by mimicking the guanosine building block. Lamivudine USP/BP 300 mg The Cytidine Analogue: A highly potent NRTI that works synergistically to block the reverse transcriptase enzyme. Excipients Proprietary Matrix Bio-Stable Coating: Engineered to ensure consistent absorption and protect the APIs from environmental degradation. Abacavir Tablets
FreeProduct Composition & Strength
We supply this product in standardized strengths to allow for both adult and pediatric weight-based dosing.
Active Ingredient Strength Primary Clinical Function Abacavir (as Sulfate) USP/BP/Ph.Eur. 300 mg The Standard Dose: Usually taken twice daily as part of a multi-drug regimen. Abacavir (as Sulfate) USP/BP/Ph.Eur. 600 mg The Once-Daily Anchor: Optimized for patient compliance in simplified treatment schedules. Excipients Proprietary Matrix Bio-Stable System: Engineered to ensure consistent oral absorption and protect the API from environmental degradation. Aciclovir Tablets
FreeProduct Composition & Strength
We supply this product in standardized strengths to cover everything from simple cold sores to severe shingles cases.
Active Ingredient Strength Primary Clinical Function Aciclovir USP/BP/Ph.Eur. 200 mg The Herpes Unit: Standard dose for the treatment and suppression of Herpes Simplex (HSV-1 and HSV-2). Aciclovir USP/BP/Ph.Eur. 400 mg The Prophylactic Anchor: Used for long-term suppression in immunocompromised patients. Aciclovir USP/BP/Ph.Eur. 800 mg The Zoster Payload: High-potency dose required to treat Shingles (Herpes Zoster) and Chickenpox. Acyclovir Dispersible Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated, Dispersible Tablets (often flavored/sweetened for palatability), packed in moisture-resistant blister strips.
Active Ingredient Strength Primary Clinical Use Acyclovir USP/BP/Ph.Eur. 200 mg HSV-1 & HSV-2 (Genital/Labial Herpes) Treatment Acyclovir USP/BP/Ph.Eur. 400 mg Recurrent HSV Suppression / Chronic Prophylaxis Acyclovir USP/BP/Ph.Eur. 800 mg Varicella (Chickenpox) & Herpes Zoster (Shingles) Excipients Crospovidone / Aspartame / Flavoring Agents Superdisintegrant / Sweetener / Taste-Masking Acyclovir injection
Freecomposition
Aciclovir 400 mg
Each Uncoated contains:
Aciclovir IP 400 mg
Excipients – QSAciclovir 200 mg
Each Uncoated Contains :
Aciclovir 200 mg
Excipients q.sUsage :- Treat infections caused by certain types of viruses
Category :- Antibiotic drugs
Therapeutic category :- Antiviral
Pcd pharma franchise :-
Pcd marketing :-
Manufacturer :- Healthy Life Pharma Pvt Ltd
Exporter :- Healthy Inc
Supplier :- Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor :- Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller :- Healthy Life Pharma Pvt Ltd
Healthy Inc
Acyclovir Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets or Dispersible Tablets (DT). The dosage varies significantly based on the viral strain being treated.
Active Ingredient Strength (Standard) Primary Indication Acyclovir USP/BP/IP 200 mg Herpes Simplex (Genital/Labial) Acyclovir USP/BP/IP 400 mg Suppression / Prophylaxis Acyclovir USP/BP/IP 800 mg Shingles (Herpes Zoster) / Chickenpox Excipients Q.S. Disintegrant / Binder Adefovir Dipivoxil Tablets
FreeProduct Composition & Strengths
We supply this therapeutic in the globally accepted standard therapeutic strength optimized for adult daily maintenance therapy.
Active Ingredient Standard Strength Primary Clinical Target Adefovir Dipivoxil IP / BP / USP 10 mg The Polymerase Blocker: Daily oral dose to suppress chronic Hepatitis B viral loads. Excipients Pharma Grade The Matrix: High-stability lactose/microcrystalline cellulose binders. Favipiravir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pyrazinecarboxamide derivative.
Active Ingredient Strength Primary Clinical Function Favipiravir USP/Ph.Eur. 200 mg The Global Outbreak Standard: Base therapeutic unit utilized for standard, highly flexible titration during acute viral hemorrhagic fevers or novel influenza outbreaks. Favipiravir USP/Ph.Eur. 400 mg / 800 mg The Pill-Burden Reduction Macrodose: Massive therapeutic payload engineered specifically to solve the severe “Day 1 Loading Dose” compliance nightmare (allowing a patient to take two 800mg pills instead of eight 200mg pills). Excipients Microcrystalline Cellulose / Crospovidone / Povidone K-30 / Colloidal Silicon Dioxide / Sodium Stearyl Fumarate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Glidant / Lubricant (Engineered specifically utilizing advanced high-shear wet granulation to compress massive, bulky API doses into smooth, easily swallowable tablets, finished with a heavy film-coat to lock out tropical humidity) *Pack Sizes: 10×10 Alu-Alu Blisters or Complete Therapy “Outbreak Kits” (e.g., 34-tablet or 40-tablet regimen boxes).
Ganciclovir Capsules
FreeGanciclovir capsules (commonly found in 250 mg and 500 mg strengths) contain the active antiviral drug ganciclovir, a synthetic guanine derivative used to treat and prevent cytomegalovirus (CMV) infections
Lamivudine Tablets
FreeProduct Composition & Available Portfolio strengths
We manufacture Lamivudine across the precise compendial strengths mandated to manage either targeted chronic hepatic monotherapy or high-potency systemic combination antiretroviral protocols.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Lamivudine USP / BP / IP 100 mg Oral Solid Film-Coated Tablet Chronic Hepatitis B (HBV): Low-dose configuration optimized for standalone daily suppression of active hepatic viral replication. Lamivudine USP / BP / IP 150 mg Oral Solid Film-Coated Tablet Standard Antiretroviral (HIV): Baseline strength designed for twice-daily co-administration or integration into standard multi-drug ARV regimens. Lamivudine USP / BP / IP 300 mg Oral High-Potency Solid Tablet High-Compliance Antiretroviral (HIV): Standard adult once-daily high-dose format engineered to optimize long-term patient compliance. Nelfinavir Tablet
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. Due to the high dose required for therapeutic efficacy, we ensure the tablet is engineered for ease of swallowing without compromising the structural integrity of the high-API load.
Active Ingredient Strength (Standard) Therapeutic Role Nelfinavir Mesylate USP/BP 250 mg Standard Adult / Pediatric Dose Nelfinavir Mesylate USP/BP 625 mg High-Strength Adult Maintenance Excipients Q.S. Calcium Silicate / Crospovidone Disintegrant & Stabilizer Oseltamivir Tablet
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Hard Gelatin Capsule, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the hygroscopic phosphate salt.
Active Ingredient Strength Primary Clinical Function Oseltamivir Phosphate USP/Ph.Eur. 75 mg (Equivalent to Oseltamivir free base) Global Standard: Target adult dose for rapid treatment and prophylaxis of Influenza A/B. Excipients Pregelatinized Starch / Croscarmellose Sodium / Povidone / Sodium Stearyl Fumarate Diluent / Superdisintegrant (Engineered for immediate gastric capsule rupture and rapid systemic absorption) *Pack Sizes: 1×10 Blisters (Optimized perfectly for the standard 5-day acute treatment regimen of two capsules daily).
Ribavirin Capsules
FreeRibavirin capsules are antiviral medications typically used in combination with other drugs (like interferon or sofosbuvir) to treat chronic Hepatitis C. They are most commonly available in a 200 mg strength, though 100 mg versions also exist.
Ribavirin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-density PVC/PVDC blister strips to ensure the stability of the active nucleoside analog and protect handlers from exposure.
Active Ingredient Strength Primary Clinical Function Ribavirin USP/Ph.Eur. 200 mg Global Clinical Standard: Base titration unit for precise, weight-based antiviral dosing. Ribavirin USP/Ph.Eur. 400 mg High-dose unit to drastically improve pill-burden compliance in heavy patients. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone / Magnesium Stearate Diluent / Superdisintegrant / Binder (Engineered for immediate gastric dissolution and rapid systemic absorption) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for high-dose, weight-based daily regimens requiring 4 to 6 tablets per day).
Sofosbuvir & Ledipasvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles containing exactly 28 tablets to perfectly align with strict clinical dispensing cycles.
Active Ingredient Strength Primary Clinical Function Sofosbuvir INN/Ph.Eur. 400 mg NS5B RNA polymerase inhibition to terminate viral RNA chain synthesis. Ledipasvir INN/Ph.Eur. 90 mg NS5A protein inhibition to halt viral replication and physical virion assembly. Excipients Copovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate Binder / Diluent / Superdisintegrant (Engineered for strict synchronized gastric dissolution) Sofosbuvir & Velpatasvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles containing exactly 28 tablets to perfectly align with strict 12-week clinical dispensing cycles.
Active Ingredient Strength Primary Clinical Function Sofosbuvir INN/Ph.Eur. 400 mg NS5B RNA polymerase inhibition to terminate viral RNA chain synthesis. Velpatasvir INN/Ph.Eur. 100 mg NS5A protein inhibition to halt viral replication and physical virion assembly. Excipients Copovidone / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate Binder / Diluent / Superdisintegrant (Engineered for strict synchronized gastric dissolution) Sofosbuvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or ultra-dense Alu-Alu blister strips to ensure the absolute chemical stability of the nucleotide analog.
Active Ingredient Strength Primary Clinical Function Sofosbuvir INN/Ph.Eur. 400 mg Global Standard: Base NS5B polymerase inhibition for daily combination HCV therapy. Excipients Mannitol / Microcrystalline Cellulose / Croscarmellose Sodium / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Superdisintegrant / Glidant (Engineered for immediate gastric dissolution and high bioavailability) Tenofovir Tablets
FreeAbivir
Tenofovir Disoproxil Fumarate Tablet 300 mg
Each Film Coated Tablet Contains:
Tenofovir Disoproxil Fumarate 300 mgUsage: – help control HIV infection
Category: – HIV Anti viral drugs
Therapeutic category: – Antiviral, Anti HIV
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Tenofovir, Lamivudine & Dolutegravir Tablets
FreeProduct Composition & Strength
We supply this product as a highly advanced Film-Coated Tablet, packed strictly in heavy-gauge HDPE bottles with integrated silica gel desiccants. This packaging is absolutely non-negotiable, as Tenofovir is highly susceptible to hydrolytic degradation in humid environments.
Active Ingredient Strength Primary Clinical Function Tenofovir Disoproxil Fumarate (TDF) INN/Ph.Eur. 300 mg Potent Nucleotide Reverse Transcriptase Inhibitor (NRTI). Lamivudine (3TC) INN/Ph.Eur. 300 mg Synergistic Nucleoside Reverse Transcriptase Inhibitor (NRTI). Dolutegravir (DTG) INN/Ph.Eur. 50 mg Advanced Integrase Strand Transfer Inhibitor (INSTI). Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Sodium Staryl Fumarate Diluent / Superdisintegrant / Lubricant (Engineered for uniform FDC dissolution) Valganciclovir Tablets
FreeProduct Composition & Strength
We supply this product as a Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles for chronic dispensing regimens.
Active Ingredient Strength Primary Clinical Use Valganciclovir Hydrochloride USP/Ph.Eur. 450 mg (Equivalent to Valganciclovir free base) Standard Adult Dose for CMV retinitis induction/maintenance and transplant prophylaxis. Excipients Povidone / Crospovidone / Microcrystalline Cellulose / Stearic Acid Binder / Superdisintegrant / Diluent (Ensures rapid gastric dispersion and prodrug integrity)
